← Open Payments lookup

CASSANDRA ROSEBRAUGH: Open Payments

NPI 1144880980 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,930 in 133 payments from 14 companies in 2025. Trend: 2023 $1,353 · 2024 $3,041 · 2025 $2,930

Food & beverage: $2,930
CompanyPaymentsAmount
Alkermes, Inc.15$442
Otsuka America Pharmaceutical, Inc.22$355
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$347
E.R. Squibb & Sons, L.L.C.11$342
Axsome Therapeutics, Inc.14$313
ABBVIE INC.13$283
Neurocrine BioSciences, Inc.8$183
Janssen Pharmaceuticals, Inc7$171
Braeburn Inc.7$157
Teva Pharmaceuticals USA, Inc.9$152

Products named: CAPLYTA, COBENFY, REXULTI, Auvelity, ARISTADA, VRAYLAR, INGREZZA, BRIXADI.

Industry payments across FL — which companies pay providers there.